The Estonian biobank is a prospective, longitudinal, population-based biobank consisting of rich health data and biological materials from 52,000 persons suitable for drug development studies, development of diagnostics tests and risk-prediction algorithms
Sequencing, genotyping and gene expression analysis, cytogenetic and cancer research studies, metagenomics, etc. for researchers, clinicians and others with the state-of-the-art Illumina technology
Areas of activity:
Estonian Biobank is the population-based biobank with the cohort size 51,515, donors with age from 18 years. Each donor has rich phenotype data including health data continuously linked with national e-registers and genomics data (2400 full genomes, 12 000 have info for 180 metabolites, 50% have genotype data obtained by Illumina chips)
More than 25 different projects are currently running (http://www.geenivaramu.ee/en/projects), incl. EU, USA, regional and national ones
Research organizations, knowledge-based companies
More than 200 partners world-wide, like Nestle, the Broad Institute, Cambridge University, Oxford University, BBMRI-ERIC, ELIXIR and P3G.